Saturday, 30 Sep 2023

Health Problems

Unlocking the Secrets of Blue Zones: A Blueprint for Longevity and Health

Characteristics of blue zonesThe science behind longevityBlue Zones worldwideHealthcare implicationsThe future of agingReferences Further reading Blue zones are places where there are ten times as many centenarians as expected for a corresponding population size in the USA, most of them being unusually healthy. American researcher Dan Buettner first highlighted Blue Zones, identifying five worldwide, from California […]

Catalyzing Change: Exploring the Evolving Landscape of Healthcare Entrepreneurship

Digital health startupsWearable technologyEmpowering patientsTelemedicineAI and machine learningPreventative careCollaborationReferencesFurther reading The healthcare industry is rapidly evolving to meet the global population's changing needs. Entrepreneurship in healthcare involves identifying, developing, and implementing solutions to improve healthcare. Innovations by healthcare entrepreneurs may target improvements in patient outcomes, the efficiency of healthcare delivery, and the value patients obtain […]

What are Recurrent Neural Networks?

Types of recurrent neural networksBidirectional recurrent neural networksLong short-term memoryGated recurrent unitsMedical uses for recurrent neural networksRecurrent neural networks and medical imagingRecurrent neural networks and diagnosticsReferencesFurther reading Recurrent neural networks are a classification of artificial neural networks used in artificial intelligence (AI), natural language processing (NLP), deep learning, and machine learning. They process temporal, sequential […]

What is Systemic Mastocytosis?

Systemic mastocytosis is a myeloid neoplasm divided into six subcategories by the recent classification by WHO. It involves the accumulation of abnormal mast cells (MCs) in the skin, liver, spleen, and bone marrow. Systemic mastocytosis is a myeloid neoplasm divided into six subcategories by the recent classification by WHO. Image Credit: SciePro/ In the 1930s, […]


Treatment for: Fungal Infections F2G Receives Complete Response Letter from FDA for New Drug Application for Olorofim for The Treatment of Invasive Fungal Infections Complete Response Letter is related to the request for additional data and analyses. F2G remains committed to bringing olorofim to patients and intends to meet with FDA in the coming months […]

Tackling Isolation When You Can’t Go Outside

The world is fighting the deadly Coronavirus pandemic. Therefore the news and social media are focused on COVID-19, its effects, and preventive measures. We’ve heard new terms like quarantine, isolation, social distancing, etc., frequently. It can get a little overwhelming, especially since we can’t meet anyone outside of the home to discuss how we’re feeling. […]

Managing Emotions during the COVID-19 Struggle

The stress of modern-day life has given birth to fluctuating feelings in most of us. So many factors influence our behavior these days that there’s no specific reason for a mood swing. And as if everyday hustle wasn’t enough, the emergence of COVID-19 has further fuelled the fire making it extremely challenging for people to […]

Diagnosis of rare, genetic muscle disease improved by new approach

It’s not easy to distinguish between the dozens of subtypes of limb girdle muscular dystrophy — a rare, genetic muscle disease characterized by weakness in the hips and shoulders that causes difficulty walking and lifting the arms. Until now, determining the subtype has not been critical in caring for patients, because no specific treatments have […]

Gordon wins Spain’s Asturias Award

Microbiome pioneer Jeffrey I. Gordon, MD, of Washington University School of Medicine in St. Louis, has won the 2023 Princess of Asturias Award for Technical and Scientific Research. The Asturias awards, among the most prestigious honors in the Spanish-speaking world, are presented annually in eight categories. The awards are designed to recognize exceptional scientific, technical, […]

Lovotibeglogene autotemcel

Treatment for: Anemia, Sickle Cell bluebird bio Submits Biologics License Application (BLA) to FDA for lovotibeglogene autotemcel (lovo-cel) for Patients with Sickle Cell Disease (SCD) 12 years and Older with a History of Vaso-Occlusive Events SOMERVILLE, Mass.–(BUSINESS WIRE)–Apr. 24, 2023– bluebird bio, Inc. (Nasdaq: BLUE) today announced the submission of its Biologics License Application (BLA) […]

Recent Posts